XBiotech (XBIT) Other Accumulated Expenses (2014 - 2025)
XBiotech (XBIT) posted quarterly Other Accumulated Expenses of $39000.0 for Q4 2025, down 55.68% year-over-year from $88000.0 in Q4 2024, and down 55.68% quarter-over-quarter from $88000.0 in Q4 2024.
XBiotech (XBIT) Other Accumulated Expenses (2014 - 2025) Analysis & Trends
XBiotech's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $39000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 55.68% year-over-year to $39000.0; the TTM figure through Dec 2025 stood at $39000.0 (down 55.68% YoY), while the FY2025 annual figure was $39000.0, down 55.68% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $39000.0, down from $88000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $113000.0 in Q4 2021, with the low at $39000.0 in Q4 2025.
- The 5-year median for Other Accumulated Expenses is $69000.0 (2022), against an average of $74000.0.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses surged 44.26% in 2024, then tumbled 55.68% in 2025.
- XBiotech's Other Accumulated Expenses stood at $113000.0 in 2021, then sank by 38.94% to $69000.0 in 2022, then retreated by 11.59% to $61000.0 in 2023, then soared by 44.26% to $88000.0 in 2024, then plunged by 55.68% to $39000.0 in 2025.
- Business Quant data shows XBIT's Other Accumulated Expenses at $39000.0 in Q4 2025, $88000.0 in Q4 2024, and $61000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 237,000.00 |
| Dec 31, 2019 | 195,000.00 |
| Dec 31, 2018 | 36,000.00 |
| Dec 31, 2017 | 30,000.00 |
| Dec 31, 2016 | 101,000.00 |
| Dec 31, 2015 | 329,000.00 |
| Dec 31, 2014 | 164,000.00 |